NCT07287280 Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications
| NCT ID | NCT07287280 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Gynecologic Surgical Procedures |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-09-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addresses comorbidities, providing simplicity and broad applicability, while POSSUM incorporates both physiological and operative factors for a more comprehensive risk assessment. Despite their application across various surgical specialties, the specific utility of these tools in onco-gynecologic surgery remains insufficiently explored. The study aims to evaluate the effectiveness of CCI and POSSUM in predicting perioperative complications, with a focus on the incidence of these complications, length of hospital stay, and 30-day mortality. The implementation of these risk tools may enhance multidisciplinary risk management, thus improving patient outcomes in gynecologic oncology surgery.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Patient underwent elective onco-gynecologic surgery Exclusion Criteria: * Patient required emergency surgery from any indication * Patient chart that not contained primary outcome data eg. absent of the anesthetic record
Contact & Investigator
Patchareya Nivatpumin, M.D.
PRINCIPAL INVESTIGATOR
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital
Frequently Asked Questions
Who can join the NCT07287280 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Surgical Procedures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07287280 currently recruiting?
Yes, NCT07287280 is actively recruiting participants. Contact the research team at patchareya.niv@mahidol.ac.th for enrollment information.
Where is the NCT07287280 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT07287280 clinical trial?
NCT07287280 is sponsored by Mahidol University. The principal investigator is Patchareya Nivatpumin, M.D. at Department of Anesthesiology, Faculty of Medicine Siriraj Hospital. The trial plans to enroll 300 participants.